Novel drugs are being developed which interact with the
programmed cell death (apoptotic) machinery in cancer cells,
thereby causing these cells to commit suicide and to be removed
from the body. Research is also directed to investigate why the
cancer cells sometimes lose the ability to undergo apoptosis after
a certain period of time and methods are being developed to
reactivate this cell death process. This book is intended for
workers in the field and clinicians as a useful guide of the state
of affairs in this exciting field which may offer more effective
possibilities for treatment of cancer patients.
Mels Sluyser is the Editor of the journals APOPTOSIS and
ANTI-CANCER DRUGS. He brings together a collection of papers
written by the world 's leading experts in these fields.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!